APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Condition:   Hematologic Malignancies Intervention:   Drug: APG-2575 Sponsor:   Ascentage Pharma Group Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials